As the most ubiquitous reversible PTM, phosphorylation operates as the primary molecular switch governing intracellular signal transduction. The dynamic equilibrium maintained by kinase and phosphatase networks directly controls the cell cycle, apoptosis, and metabolic flux. Dysregulation within cascades such as the PI3K/AKT or MAPK/ERK pathways routinely drives malignant transformation. Explore our validated, site-specific antibodies targeting serine, threonine, and tyrosine phosphorylations to precisely map complex signaling cascades, evaluate novel kinase inhibitor efficacy, and profile receptor tyrosine activation.
Hot products 
-
Mouse Anti-BACE1 Recombinant Antibody (CBLNB-121) (CBMAB-1180-CN)
-
Mouse Anti-ADV Recombinant Antibody (V2-503423) (CBMAB-V208-1364-FY)
-
Mouse Anti-BrdU Recombinant Antibody (IIB5) (CBMAB-1038CQ)
-
Mouse Anti-CCT6A/B Recombinant Antibody (CBXC-0168) (CBMAB-C5570-CQ)
-
Mouse Anti-CD247 Recombinant Antibody (6B10.2) (CBMAB-C1583-YY)
-
Mouse Anti-dsDNA Recombinant Antibody (22) (CBMAB-AP1954LY)
-
Mouse Anti-BRCA2 Recombinant Antibody (CBYY-1728) (CBMAB-2077-YY)
-
Rat Anti-ADGRE4 Recombinant Antibody (V2-160163) (CBMAB-F0011-CQ)
-
Mouse Anti-AKT1/AKT2/AKT3 (Phosphorylated T308, T309, T305) Recombinant Antibody (V2-443454) (PTM-CBMAB-0030YC)
-
Mouse Anti-CD1C Recombinant Antibody (L161) (CBMAB-C2173-CQ)
-
Mouse Anti-BIRC3 Recombinant Antibody (315304) (CBMAB-1214-CN)
-
Mouse Anti-GFAP Recombinant Antibody (20) (CBMAB-G2914-LY)
-
Rat Anti-CCR2 Recombinant Antibody (475301) (CBMAB-C1338-LY)
-
Mouse Anti-BRD3 Recombinant Antibody (CBYY-0801) (CBMAB-0804-YY)
-
Rabbit Anti-ALDOA Recombinant Antibody (D73H4) (CBMAB-A2314-YC)
-
Mouse Anti-FLI1 Recombinant Antibody (CBXF-0733) (CBMAB-F0435-CQ)
-
Mouse Anti-ABL2 Recombinant Antibody (V2-179121) (CBMAB-A0364-YC)
-
Mouse Anti-EMP3 Recombinant Antibody (CBFYE-0100) (CBMAB-E0207-FY)
-
Mouse Anti-GFAP Recombinant Antibody (24) (CBMAB-G2927-LY)
-
Mouse Anti-FOXL1 Recombinant Antibody (CBXF-0845) (CBMAB-F0462-CQ)
Explore High-Affinity Antibody by Post-Translational Modification (PTM)
Post-translational modifications (PTMs) represent a critical layer of biological regulation, dynamically expanding the structural and functional diversity of the proteome long after genomic translation. By orchestrating covalent additions, lipid attachments, or proteolytic cleavages, PTMs dictate protein conformation, subcellular localization, interactome networks, and intrinsic catalytic activity. The precise quantification and spatial resolution of these highly transient states are paramount for delineating complex cellular signaling architectures and understanding the molecular etiology of severe pathologies, including oncogenesis, neurodegeneration, and systemic autoimmune disorders.
Traditional genomic and transcriptomic approaches fail to capture this fundamental layer of physiological regulation. Accurate PTM interrogation mandates analytical reagents with exceptional target specificity and structural fidelity. Because modified and unmodified protein precursors often share identical primary sequences and high structural homology, distinguishing between them requires antibodies engineered for absolute precision. Our curated portfolio of high-affinity PTM-specific antibodies provides the stringent differentiation required to isolate and quantify specific modified epitopes, ensuring reproducible data across demanding experimental paradigms.
Navigate Our Specialized PTM Antibody Portfolios
Select a modification category below to access our comprehensive collection of PTM-specific antibodies, each rigorously validated across Western blot, immunoprecipitation, and multiplex imaging platforms to accelerate your discovery pipeline.
The ubiquitin-proteasome system (UPS) governs fundamental cellular homeostasis by regulating protein half-life and turnover kinetics. The specific linkage topology of polyubiquitin chains dictates highly distinct cellular fates: K48-linked chains typically direct substrates for proteasomal degradation, while K63-linked chains mediate DNA damage repair and endosomal trafficking. Access our highly specific antibodies engineered to differentiate between mono-ubiquitination and distinct polyubiquitin chain linkages, providing essential tools for elucidating degradation kinetics and advancing therapeutic targeted protein degradation research.
Epigenetic regulation relies fundamentally on the precise acetylation and methylation of histone tails, modifications that dynamically govern chromatin architecture and transcriptional accessibility. Beyond histone targets, these modifications critically regulate non-histone proteins, influencing the activity of core metabolic enzymes and structural protein dynamics. Utilize our exquisite affinity reagents targeting specific epigenetic "writers," "readers," and "erasers" to accurately profile epigenetic landscapes, identify crucial chromatin remodeling events, and investigate transcription factor activation states.
Ubiquitin-like modifiers, primarily SUMO and NEDD8, induce profound structural conformational changes that drastically alter protein-protein interactomes and subcellular localization. SUMOylation frequently operates antagonistically to ubiquitination, sequestering and stabilizing target proteins within nuclear bodies. Conversely, NEDDylation is an absolute prerequisite for the catalytic activation of cullin-RING ligases. Discover our specialized antibodies specifically designed to enrich and detect low-abundance SUMOylated and NEDDylated targets, delivering superior signal-to-noise ratios in complex cellular lysates.
The complex enzymatic attachment of carbohydrate structures to nascent proteins dictates essential folding mechanics, thermodynamic stability, and extracellular receptor interactions. Intracellularly, rapid O-GlcNAcylation heavily influences nutrient sensing pathways and frequently competes with phosphorylation for identical serine/threonine residues. Aberrant extracellular glycosylation patterns serve as well-established biomarkers for tumor progression and immune evasion. Browse our selection of antibodies specific to distinct glycan linkages and core glycoproteins, facilitating the detailed study of cellular adhesion dynamics and tumor microenvironment communication.
Loading...



